HAEMONETICS CORP
For the period ended Jun 29, 2024. Filed Aug 8, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 29, 2024 · Filed Aug 8, 2024
HAE$118.21-1.4%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. Financial Statements
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
(Unaudited in thousands, except per share data)
| Three Months Ended | ||
|---|---|---|
| June 29,2024 | July 1,2023 | |
| Net revenues | $336,172 | $311,332 |
| Cost of goods sold | 161,248 | 144,067 |
| Gross profit | 174,924 | 167,265 |
| Operating expenses: | ||
| Research and development | 14,449 | 12,648 |
| Selling, general and administrative | 108,248 | 93,485 |
| Amortization of acquired intangible assets | 12,471 | 7,473 |
| Total operating expenses | 135,168 | 113,606 |
| Operating income | 39,756 | 53,659 |
| Interest and other income (expense), net | 6,957 | (2,069) |
| Income before provision for income taxes | 46,713 | 51,590 |
| Provision for income taxes | 8,340 | 10,548 |
| Net income | $38,373 | $41,042 |
| Net income per share - basic | $0.75 | $0.81 |
| Net income per share - diluted | $0.74 | $0.80 |
| Weighted average shares outstanding | ||
| Basic | 50,943 | 50,542 |
| Diluted | 51,564 | 51,340 |
| Comprehensive income | $31,338 | $41,905 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.